ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
73.99 -0.34  -0.46% NASDAQ Sep 4, 20:00 Delayed 2m USD
View Full Chart
BIB Price Chart

BIB Key Stats

Expense Ratio (8-17-15) 0.95%
Assets Under Management (9-4-15) 820.44M
30-Day Average Volume (9-4-15) 1.057M
Net Asset Value (9-4-15) 73.91
Discount or Premium to NAV (9-4-15) 0.11%
Turnover Ratio (5-31-15) 41.00%

BIB Asset Allocation

Type % Net % Long % Short
Cash -96.38% 38.48% 134.9%
Stock 152.9% 156.6% 3.74%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 43.50% 43.50% 0.00%
As of June 30, 2015

BIB Region Exposure

Americas 97.27%
North America 97.27%
Latin America 0.00%
Greater Europe 2.69%
United Kingdom 1.92%
Europe Developed 0.72%
Europe Emerging 0.00%
Africa/Middle East 0.05%
Greater Asia 0.04%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.04%
Market Classification
% Developed Markets 99.96%
% Emerging Markets 0.04%
As of June 30, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of June 30, 2015

BIB Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of June 30, 2015
View More Holdings

BIB Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Credit Suisse International 67.07% -- --
-- Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 27.88% -- --
-- Ishares Biotech (Ibb) Swap Deutsche Bank Ag 8.89% -- --
-- Nasdaq Biotechnology Index Swap Ubs Ag 7.64% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America, Na 5.76% -- --
-- Ishares Biotech (Ibb) Swap Bank Of America, Na 5.10% -- --
GILD Gilead Sciences Inc 5.07% 102.06 +0.15%
BIIB Biogen Inc 4.95% 302.26 +0.21%
CELG Celgene Corp 4.92% 117.39 -0.22%
AMGN Amgen Inc 4.78% 147.02 -1.48%
As of June 30, 2015
Advertisement

BIB Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Prospectus Objective Specialty - Health
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
200.0%

BIB Manager Info

Name Tenure
Charles Lowery 1.83 yrs
Michael Neches 1.83 yrs

BIB Risk Info

Beta 1.743
Max Drawdown (All) 41.44%
Historical Sharpe (10y) --
Historical Sortino (All) 3.501
30-Day Rolling Volatility 71.96%
Daily Value at Risk (VaR) 1% (All) 7.69%
Monthly Value at Risk (VaR) 1% (All) 30.77%

BIB Fundamentals

Dividend Yield TTM (9-4-15) 0.00%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield 0.22%
Forecasted PE Ratio 27.02
Forecasted Price to Sales Ratio 8.320
Forecasted Price to Book Ratio 7.305
Number of Holdings 168
As of June 30, 2015

BIB Growth Estimates

Forecasted 5 Yr Earnings Growth 13.60%
Forecasted Book Value Growth 13.40%
Forecasted Cash Flow Growth 30.02%
Forecasted Earnings Growth 36.58%
Forecasted Revenue Growth 15.23%
As of June 30, 2015

BIB Performance

  Returns Total Returns
1M -23.82% -23.82%
3M -15.54% -15.54%
6M -5.26% -5.26%
1Y 44.72% 44.72%
3Y 395.7% 395.7%
5Y 1177% 1194%
As of Sept. 4, 2015

BIB Net Flows

1M 66.26M
3M 4.835M
6M 190.03M
YTD 202.24M
1Y 318.55M
3Y 466.27M
5Y 484.17M
As of Aug. 31, 2015

BIB Attributes

Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2015
Last Prospectus Date 8/17/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

BIB Excel Add-In Codes

  • Name: =YCI("BIB","name")
  • Broad Asset Class: =YCI("BIB", "broad_asset_class")
  • Broad Category: =YCI("BIB", "broad_category_group")
  • Prospectus Objective: =YCI("BIB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.